[j]朱丽娟，刘志强，刘志强，刘志强，刘志强，刘志强，刘志强，刘志强，刘志强，刘志强，刘志强，刘志强，刘志强，刘志强，刘志强，刘志强，刘志强，刘志强，刘志强，等。网络正念干预对恶性肿瘤患者心理健康影响的研究进展。可用性研究JO - J Med Internet Res SP - e17526 VL - 22 IS - 10 KW -互联网干预KW - eHealth KW -正念KW -基于正念的认知疗法KW -使用KW -日志数据KW -摄取KW -坚持KW -癌症KW -肿瘤AB -背景:三分之一的癌症患者经历高度的心理困扰。正念为基础的干预措施是有效的，以减少心理困扰，在这个病人组。然而，这些干预措施缺乏可用性和灵活性，这可能会影响到出现疲劳或疼痛等晚期症状的癌症患者参与干预。因此，正念干预越来越多地通过互联网提供。然而，人们对这些基于正念的在线干预措施的使用知之甚少。目的:本研究的目的是:(1)使用基线患者特征(人口统计学、癌症相关、个性和心理变量)预测在线正念认知治疗(eMBCT)的接受和坚持;(2)检查癌症患者的eMBCT治疗依从性与治疗结果之间的关系。方法:在一项父母随机对照试验中，共有125名癌症患者被分配到eMBCT，比较MBCT和eMBCT与常规治疗的痛苦癌症患者。在在线程序中自动跟踪eMBCT的各种使用措施。根据使用活动，参与者被分为非用户、最小用户、低用户和预期用户。 Questionnaires were used to assess baseline characteristics (preintervention) and outcomes (pre- and postintervention). To answer the research questions, data were analyzed with t tests, χ2 tests, and linear regression models. Results: Based on weekly activity, participants were classified as nonusers (n=17, 13.6%), who completed no exercises in MBCT; minimal users (n=31, 24.8%), who completed at least one exercise of one to three sessions; low users (n=12, 9.6%), who completed at least one exercise of four to seven sessions; and intended users (n=65, 52.0%), who completed at least one exercise of eight to nine sessions. Nonusers had more fear of cancer recurrence at baseline than users (uptake), and intended users were more conscientious than minimal and low users (adherence). Intended users reported a larger reduction in psychological distress and more improvement of positive mental health (ie, emotional, psychological, and social well-being) after the intervention than other participants. Conclusions: This study showed that adherence was related to improved patient outcomes. Patients with strong fear of recurrence or low levels of conscientiousness should receive extra attention, as they are less likely to respectively start or complete eMBCT. Future research may focus on the development of flexible and adaptive eMBCT programs to fit individual needs. SN - 1438-8871 UR - //www.mybigtv.com/2020/10/e17526 UR - https://doi.org/10.2196/17526 UR - http://www.ncbi.nlm.nih.gov/pubmed/33006567 DO - 10.2196/17526 ID - info:doi/10.2196/17526 ER -